Dr. Sonenberg is world-renowned as a leading expert in translational control mechanisms, making seminal contributions to our understanding of translation, and notably for the discovery of the mRNA 5' cap-binding protein, eIF4E, the rate-limiting component of the eukaryotic translation apparatus.  He is a recipient of the Robert L. Nobel Prize of the National Cancer Institute of Canada, the Killiam Prize for Health Sciences, the Gairdner Foundation International Award, the Rosenstiel Award and the Wolf Prize in Medicine, among many others.  Dr. Sonenberg is a Professor and Gilman Cheney Chair in the Department of Biochemistry at McGill University and Principal Investigator at the Rosalind and Morris Goodman Cancer Center.